The Wellness Files with Kari Beal

FOX Carolina News
  • 4.4 (7)
  • Fitness
  • Updated Biweekly

The Wellness Files is a health-focused podcast where we explore practical tools, research and real patient stories. We hope to inform, inspire, and connect to audiences so you can be the best version of yourself, while also asking tough questions about safety and effectiveness.

  1. 6d ago

    Retatrutide Explained: Unprecedented Weight Loss, Unique Side Effects, and the Risks

    In this episode of The Wellness Files, host Kari Beal sits down with obesity medicine specialist Dr. Christopher McGowan to discuss Retatrutide, the highly anticipated "triple agonist" weight loss drug currently in Phase 3 trials. They dive into its unprecedented weight loss potential, unique side effects like skin sensitivity, and the dangerous black market pathways patients are using to access it before FDA approval.  00:00 – Intro: The massive hype surrounding Retatrutide ("RETA")01:58 – The dangers of seeking unapproved research drugs online02:47 – Weight loss data: Reta's gastric bypass-level results vs. Wegovy https://www.nejm.org/doi/full/10.1056/NEJMoa230197204:22 – How the "triple G" agonist works on three gut hormones07:04 – The reality of muscle loss and preserving lean mass08:41 – Side effects: Elevated heart rate and painful skin sensitivity11:13 – Thyroid cancer warnings, pancreatitis, and contraindications13:10 – Long-term safety: GLP-1 history vs. the new glucagon pathway14:59 – Additional health benefits: Reversing fatty liver and joint pain16:25 – The TikTok "Ratatouille" trend and black market peptide risks19:47 – Projected FDA approval timeline and safe, legal alternatives

    Retatrutide Explained: Unprecedented Weight Loss, Unique Side Effects, and the Risks

  2. Aug 12

    The Future of Flu Protection: Dr. Noc Breaks Down mRNA Flu Vaccine, Clinical Safety Data, and Public Trust

    Science communicator Morgan McSweeney, PhD (known online as "Dr. Noc"), joins the podcast to explain how emerging mRNA flu vaccines differ from traditional egg-grown shots and details the latest clinical trial data on their efficacy and side effects. We broaden the conversation on mRNA vaccines, provide critical context on rare risks like myocarditis (heart inflammation), and outline how safety is actively monitored. 00:00 – Explaining mRNA vaccine technology versus traditional egg-grown flu shots.02:12 – Addressing common genetic misconceptions and how mRNA is cleared from the body.04:40 – Highlighting Phase III clinical trial data, vaccine efficacy, and side effects.08:10 – Selecting the right flu vaccine based on age, health history, and doctor consultation.09:55 – Clarifying clinical trial cardiac safety data and mRNA heart inflammation risks.11:49 – Putting rare side effects in context with the severe health risks of contracting the flu.14:22 – Highlighting regional flu risks in South Carolina and protecting vulnerable communities.16:09 – Actionable advice for natural immune support, including sleep, diet, and exercise.18:09 – Detailing how federal agencies monitor vaccines for rare safety signals.20:54 – Navigating vaccine hesitancy and improving patient-doctor communication.

    The Future of Flu Protection: Dr. Noc Breaks Down mRNA Flu Vaccine, Clinical Safety Data, and Public Trust

  3. Aug 5

    A breakthrough pancreatic cancer pill, plus why diabetes could be a warning sign

    Gastroenterologist Dr. Veeral Oza explains why pancreatic cancer is so hard to catch early and how a new oral KRAS-targeting drug, known as daraxonrasib, is showing promising survival gains for some patients. He also shares a key early red flag doctors don’t want you to ignore: new-onset diabetes after age 50 (or sudden worsening control) 00:00 intro00:03 Why pancreatic cancer is often caught late; what “earlier detection” could look like.00:04 Stats + why this disease is so lethal; spotlight on the new drug.00:05 Cancer biology basics; KRAS and how tumors “hide” from the immune system.00:06 How Daraxonrasib works (switch/clamp concept) + survival improvement discussion.00:08 Why cancers adapt; why personalized medicine may be the future.00:09 Immunotherapy and “cancer vaccine” concept explained.00:11 Side effects + why an oral pill with minimal hair loss matters.00:13 How doctors handle biopsy timing, referrals, and the diagnosis conversation.00:17 “Breakthrough therapy”/expanded access: what it means for availability.00:18 What’s next: AI + earlier diagnosis research; diabetes as a major warning sign.00:20 Symptoms of diabetes; when to ask “could this be pancreatic?”00:22 Blood-test screening research + survival trends improving over time.00:24 Other possible symptoms: weight loss, jaundice, fatigue; anatomy explains why.00:28 Wrap-up + key takeaway: don’t ignore unexplained weight loss or glucose changes.

    A breakthrough pancreatic cancer pill, plus why diabetes could be a warning sign

  4. Jul 30

    Internal Sunscreen: The Foods That Help Protect Your Skin From the Sun

    Functional medicine doctor Katherine Birchenough and nutrition coach Sarah Wilson explain the “internal sunscreen” trend, how plant pigments and certain nutrients may build up in skin and help reduce UV-related damage. They stress it’s an extra layer of defense (not a replacement for topical sunscreen) and share practical food picks, supplement options, and common sun-safety myths. 00:00 – intro00:01 – Why summer produce matters; pigments from plants can accumulate in skin and help reflect UV rays.00:02 – Guests’ backgrounds; nutrition as one “layer” of sun protection.00:03 – Lycopene spotlight: tomatoes/tomato paste; studies suggest less UV redness after weeks of intake; cooked + olive oil may help absorption.00:04 – Other lycopene foods (watermelon, red/pink produce); broader pigments: blues/purples (anthocyanins), yellow/orange (flavonoids).00:06 – Layered protection: mineral sunscreen, clothing, hats/scalp protection.00:08 – Supplements: lycopene; Polypodium leucotomos (fern extract/Heliocare); repair support like nicotinamide (B3).00:10 – Omega-3s for cell membranes; astaxanthin (seafood) for antioxidant support + “glow.”00:13 – Vitamins C & E for collagen/antioxidant repair.00:14 – Myth-busting: tans aren’t enough; clouds still burn; darker skin can burn; timing + daily face/hand SPF; driving-side sun damage.00:16 – Takeaways: eat the rainbow—brighter/darker pigments = better.

    Internal Sunscreen: The Foods That Help Protect Your Skin From the Sun

  5. Jul 22

    Should the Military Screen Testosterone Levels? An Endocrinologist Explains

    Defense Secretary Pete Hegseth announced a new testosterone-deficiency screening program for service members, but endocrinologist and former military doctor Dr. Karl Nadolsky says the science doesn’t support universal testing in people without symptoms. In this episode, we break down who should be evaluated, why obesity/sleep apnea and certain injuries or medications can lower testosterone, and what risks come with unnecessary testosterone replacement therapy (including infertility). 00:00 intro00:01:00 Meet Dr. Karl Nadolsky (endocrinologist, former military physician)00:02:02 Full clip: Pete Hegseth explains annual testing for 30+; optional under 3000:04:31 What testosterone does/doesn’t do for performance; who truly benefits from TRT00:05:30 How common is “true” hypogonadism vs functional low T (obesity/sleep apnea/diabetes)00:06:48 Why widespread screening isn’t recommended; lack of evidence for better outcomes00:08:44 Medication/injury causes: opioids, TBI, blast/testicular trauma; why targeted screening fits00:11:59 Main risks: false positives, wrong timing/conditions for labs, unnecessary anxiety/cost00:13:38 Proper workup: treat root causes first; don’t miss pituitary disease or sleep apnea00:14:06 TRT tradeoffs: fertility suppression, potential long-term dependence; steroid/male-clinic pitfalls00:16:16 Women and testosterone: testing mostly for high levels; limited menopause libido use00:19:29 Military endocrinology + why expert input/task force matters for policy00:22:15 Practical alternative: checkbox-based risk triggers and symptom screening at annual physicals00:23:34 Closing: keep politics out; follow data and build evidence-based protocols

    Should the Military Screen Testosterone Levels? An Endocrinologist Explains

  6. Jul 14

    Are Peptides Safe? What a doctor Says About BPC-157, TB-500, and Buying Peptides Online

    Host Kari Beal interviews Dr. George Ibrahim about the surge in peptide use for injury recovery, energy, weight loss, and more, plus why many peptides aren’t FDA-approved and have limited human data. They break down common peptides (BPC-157, TB-500, CJC-1295/ipamorelin), discuss safety and cancer/angiogenesis concerns, and explain why buying “research peptides” online can be risky. 00:00 intro00:01 BPC-157 & TB-500 explained (repair/cleanup crews); angiogenesis + cancer concern setup.00:03 What a peptide is; how structure drives function (key/receptor).00:05 Evidence overview (animal vs limited human); why combine BPC-157 + TB-500.00:07 Safety in practice: “peptide flush” and minor reactions.00:08 Cancer-risk discussion; screening for cancer history.00:10 Quality control: pharmacy “human-use” vs online “research” peptides; contamination/dosing risks.00:12 How to tell: if you can buy it yourself online, it’s not human-use.00:14 “Best” peptide pick: CJC-1295 + ipamorelin; growth-hormone support + realistic timeline.00:17 Cost estimates; prioritizing hormones, then GH support.00:18 Why few human trials (patents/funding).00:20 FDA/compounding outlook; regulation and safety hopes.00:22 Social media hype; questions to ask a doctor; special cautions (GLP-1s, tanning peptides).00:24 More peptide uses (GHK-Cu for brain + hair/skin/nails); closing + correction (“endotoxins”).

    Are Peptides Safe? What a doctor Says About BPC-157, TB-500, and Buying Peptides Online

  7. Jul 8

    How close are we to a cure for Hunter Syndrome?

    A new FDA-approved treatment for Hunter syndrome (MPS II) is giving families hope, but it’s not a cure. We explore how close researchers may be to a cure, including promising gene therapy clinical trials, and what experts say still needs long-term study. 00:00 intro00:45 How this story began: a mom reaches out about newly approved Avlayah.01:03 Why it matters: therapy designed to cross the blood-brain barrier.01:20 The emotional center: two moms bond while navigating the same diagnosis.02:23 Hunter syndrome (MPS II) explained: missing enzyme, sugar buildup, organ/brain damage.03:40 How the “next-gen” enzyme replacement works using an enzyme transport vehicle.04:16 Early impact: reported behavioral/physical improvements and infusion-center support.05:36 “Not a cure” → what a cure could look like; intro to gene therapy.06:23 London trial spotlight: one-time ex vivo gene therapy; early (anecdotal) improvements. https://www.gosh.nhs.uk/news/gosh-manufactures-new-gene-therapy-for-rare-condition/08:01 U.S. clinical trial in New Jersey: timelines and what’s still unknown. https://clinicaltrials.gov/study/NCT0723660608:48 Physician Assistant Laura Buch: long-term durability, dosing questions, and rare-disease trial limits.10:03 Advocacy + how to find trials on ClinicalTrials.gov; closing thoughts.https://clinicaltrials.gov/study/NCT03566043

    How close are we to a cure for Hunter Syndrome?

  8. Jul 1

    Psychedelic Therapy: Why so many patients are asking for the option

    The federal government is fast-tracking some psychedelic-based medicines for research and development. Emergency physician Dr. Jonathan Leak explains how these therapies may work in the brain and if they’re safe. 00:00 — Fire captain recounts suicidal crisis; psilocybin changes his outlook and family life00:36 — Intro: what psychedelics might do (neurotransmitters/neuroplasticity) and the safety question00:54 — Why now: executive order to speed development; focus on treatment-resistant depression, PTSD, addiction01:23 — Arizona psilocybin trial for first responders; content warning for sensitive topics02:05 — Mark Herman’s story: chronic trauma, “fight or flight,” and seeking relief03:01 — Research barriers from past criminalization; trial details and demand/waitlist04:22 — Career risks/stigma for officers; underground use; dosing and safety concerns05:01 — Black market concerns; funding push; hopes for right-to-try and guardrails as access expands07:20 — Interview begins: Dr. Leak’s credentials; ketamine currently used in psychedelic therapy08:15 — What drugs are discussed: psilocybin, ibogaine, methylone/MDMA09:00 — Evidence/history; why these may help PTSD, depression, addiction10:53 — How they may work: receptors + neuroplasticity + psychedelic experience; importance of therapy integration12:36 — Brain connectivity shifts; new pathways; how psilocybin is dosed and how long sessions last15:01 — Patents/formulations; molecule tweaks vs process patents16:02 — MDMA/methylone differences; trauma processing and study outcomes; need for certified care18:08 — Clinic model questions; side effects, monitoring, and scaling sessions safely

    Psychedelic Therapy: Why so many patients are asking for the option
See All (35)

Ratings & Reviews

4.4
out of 5
7 Ratings

About

The Wellness Files is a health-focused podcast where we explore practical tools, research and real patient stories. We hope to inform, inspire, and connect to audiences so you can be the best version of yourself, while also asking tough questions about safety and effectiveness.

Information